[go: up one dir, main page]

AU4395399A - Five-membered heteroaryl compounds - Google Patents

Five-membered heteroaryl compounds

Info

Publication number
AU4395399A
AU4395399A AU43953/99A AU4395399A AU4395399A AU 4395399 A AU4395399 A AU 4395399A AU 43953/99 A AU43953/99 A AU 43953/99A AU 4395399 A AU4395399 A AU 4395399A AU 4395399 A AU4395399 A AU 4395399A
Authority
AU
Australia
Prior art keywords
membered heteroaryl
heteroaryl compounds
compounds
membered
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43953/99A
Inventor
Akihiro Kawara
Tomio Kimura
Akira Nakao
Takaichi Shimozato
Keisuke Suzuki
Shigeru Ushiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU4395399A publication Critical patent/AU4395399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU43953/99A 1998-07-02 1999-07-01 Five-membered heteroaryl compounds Abandoned AU4395399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10/187339 1998-07-02
JP18733998 1998-07-02
PCT/JP1999/003549 WO2000001688A1 (en) 1998-07-02 1999-07-01 Five-membered heteroaryl compounds

Publications (1)

Publication Number Publication Date
AU4395399A true AU4395399A (en) 2000-01-24

Family

ID=16204278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43953/99A Abandoned AU4395399A (en) 1998-07-02 1999-07-01 Five-membered heteroaryl compounds

Country Status (2)

Country Link
AU (1) AU4395399A (en)
WO (1) WO2000001688A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781552B2 (en) * 1999-11-12 2005-05-26 Merck Sharp & Dohme Corp. Diaryl piperidyl pyrrole derivatives as antiprotozoal agents

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310052B1 (en) 1996-06-04 2001-10-30 Queen's University At Kingston Nitrate esters and their use for neurological conditions
US7301021B2 (en) 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
ATE266399T1 (en) 1998-08-20 2004-05-15 Smithkline Beecham Corp NEW SUBSTITUTED TRIAZOLE COMPOUNDS
EP1126852B1 (en) 1998-11-04 2004-01-21 SmithKline Beecham Corporation Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
US6548529B1 (en) 1999-04-05 2003-04-15 Bristol-Myers Squibb Company Heterocyclic containing biphenyl aP2 inhibitors and method
US7122666B2 (en) 1999-07-21 2006-10-17 Sankyo Company, Limited Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
HUP0203403A3 (en) 1999-11-22 2004-01-28 Smithkline Beecham Plc New imidazole derivatives, pharmaceutical compositions containing them and their use
US7053098B1 (en) 1999-11-23 2006-05-30 Smithkline Beecham Corporation 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors
WO2001038312A1 (en) 1999-11-23 2001-05-31 Smithkline Beecham Corporation 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
EP1233950B1 (en) 1999-11-23 2005-10-05 Smithkline Beecham Corporation 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
US7235551B2 (en) 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
EP1352906A4 (en) * 2001-01-18 2004-06-16 Sankyo Co Compositions for prevention or treatment of hepatopathy
WO2002057255A1 (en) * 2001-01-22 2002-07-25 Sankyo Company, Limited 4- or 5-substituted pyrrole derivatives
GB0112348D0 (en) 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
US7446106B2 (en) 2001-09-05 2008-11-04 Smithkline Beecham Plc Pyridylfurans and pyrroles as Raf kinase inhibitors
AR039241A1 (en) 2002-04-04 2005-02-16 Biogen Inc HETEROARILOS TRISUSTITUIDOS AND METHODS FOR ITS PRODUCTION AND USE OF THE SAME
CA2492033A1 (en) 2002-07-09 2004-01-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (en) 2004-12-24 2006-10-06 Boehringer Ingelheim Int INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
TWI362930B (en) 2007-04-27 2012-05-01 Purdue Pharma Lp Trpv1 antagonists and uses thereof
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
WO2012176061A1 (en) 2011-06-22 2012-12-27 Purdue Pharma L.P. Trpv1 antagonists including dihydroxy substituent and uses thereof
PL224418B1 (en) 2012-09-26 2016-12-30 Univ Jagiellonski New pyrrole derivatives and process for their preparation
US9090618B2 (en) 2012-12-27 2015-07-28 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300141A (en) * 1992-01-13 1994-07-29 Smithkline Beecham Corp NOVEL IMIDAZOLE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
DE69433501T2 (en) * 1993-11-08 2004-11-04 Smithkline Beecham Corp. OXAZOLES FOR TREATING CYTOKINE MEDIATED DISEASES
US5559137A (en) * 1994-05-16 1996-09-24 Smithkline Beecham Corp. Compounds
DK0797575T3 (en) * 1994-12-13 2004-02-16 Hoffmann La Roche Imidazole derivatives as protein kinase inhibitors, especially EGF-R tyrosine kinase
US5908858A (en) * 1996-04-05 1999-06-01 Sankyo Company, Limited 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781552B2 (en) * 1999-11-12 2005-05-26 Merck Sharp & Dohme Corp. Diaryl piperidyl pyrrole derivatives as antiprotozoal agents

Also Published As

Publication number Publication date
WO2000001688A1 (en) 2000-01-13

Similar Documents

Publication Publication Date Title
AU4395399A (en) Five-membered heteroaryl compounds
AU5546000A (en) Compounds
AU1278701A (en) Novel compounds
AU1978699A (en) Heterocyclic compounds
AU2408300A (en) Novel compounds
AUPQ441499A0 (en) Novel compound
AU1746401A (en) Compounds
AU6032100A (en) New compounds
AU3997700A (en) Anti-first-pass effect compounds
AU1488001A (en) Stabilized thyroxine compounds
AUPP921299A0 (en) New heterocyclic compounds
AU4132200A (en) Novel compounds
AU5887400A (en) Derivative compounds
AU2109700A (en) Novel compounds
AU5787901A (en) Compound
AU1682400A (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU3730699A (en) Heterocyclic compound
AU2668000A (en) Bis-styrylbiphenyl compounds
AU5119400A (en) Compounds
AU2288900A (en) Novel compounds
AU4156800A (en) Novel compounds
AU2725599A (en) Substituted alxoxycarbonyl compounds
AU6168900A (en) Compounds
AU7784700A (en) Novel compounds
AU1385701A (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase